Stattlich Pharmaceuticals Private Limited

Stattlich Pharmaceuticals Private Limited - trading in Amravati, Maharashtra, India. FY 2026 financials & compliance.
CIN U51909MH2016PTC285349 Incorporated 30 August 2016 ROC Nagpur HQ Amravati, Maharashtra, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2021
₹15.03 Lakh
▼ 8% YoY
Net loss · FY 2021
₹2,715
Net margin -0.2%
EBITDA · FY 2021
-₹2,715
EBITDA margin -0.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Stattlich Pharmaceuticals Private Limited

Data last updated:

Stattlich Pharmaceuticals Private Limited is a private limited company based in Amravati, Maharashtra, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 30 August 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U51909MH2016PTC285349. Its GSTIN is 27AAXCS5617F1ZU (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vinod Jivanrao Thakare and Rajesh Ramdas Manke.

Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Madhuban Colony Shanti Nagar Yavatmal Road B/H Gurudeo Provision New Town Badnera, Amravati, Maharashtra, India – 444701.

As per the financials filed for FY 2021, the company reported a revenue of ₹15.03 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net loss of ₹2,715 (net margin -0.2%) and EBITDA of -₹2,715 (EBITDA margin -0.2%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Stattlich Pharmaceuticals Private Limited
CIN U51909MH2016PTC285349
Registration Number 285349
Incorporation Date 30 August 2016
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 November 2021
Date of Balance Sheet 31 March 2021
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Madhuban Colony Shanti Nagar Yavatmal Road B/H Gurudeo Provision New Town Badnera, Amravati, Maharashtra, India – 444701
  • Industry
    Trading, Other Wholesale, Wholesale
Comprehensive company report
Stattlich Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Stattlich Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Stattlich Pharmaceuticals Private Limited in one report.

Financials from FY 2017 Directors & ownership Charges & compliance

Business Activity of Stattlich Pharmaceuticals Private Limited

The main business activity of Stattlich Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Stattlich Pharmaceuticals Private Limited FY 2021 filings available

Stattlich Pharmaceuticals Private Limited reported revenue of ₹15.03 Lakh (down 8% YoY) for FY 2021.

Revenue · FY 2021
₹15.03 Lakh ▼ 8%
Net loss · FY 2021
₹2,715 margin -0.2%
EBITDA · FY 2021
-₹2,715 margin -0.2%

Compounded Annual Growth Rate (CAGR) of Stattlich Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▼ 8%
EBITDA CAGR growth
1 year
▼ 146%
3 years · compounded
▲ 56%

Revenue has declined at a compounded annual rate (CAGR) of 8% over three years, including a 8% fall in the latest year. EBITDA fell 146% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Stattlich Pharmaceuticals Private Limited

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA-₹2,715••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹2,715••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Stattlich Pharmaceuticals Private Limited

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin-0.2%••••••••••••••••
Net Profit Margin-0.2%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Stattlich Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2017

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Stattlich Pharmaceuticals Private Limited

Stattlich Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Moon Rock Pharmaceuticals Private Limited₹15.08 Lakh (FY 2025)••••••••21.0%••••Jind, Haryana, India
Synthecis Pharmaceuticals Private Limited₹15.07 Lakh (FY 2025)••••••••854.0%••••Hyderabad, Telangana, India
Awesome Pharmaceuticals Private Limited₹15.06 Lakh (FY 2025)••••••••-71.0%••••Lucknow, Uttar Pradesh, India
Kalysta Pharmaceuticals Private Limited₹15.06 Lakh (FY 2018)••••••••••••Mumbai, Maharashtra, India
Eshwar Pharmaceuticals LLP₹15.04 Lakh (FY 2021)••••••••86.0%••••Hyderabad, Telangana, India
Stattlich Pharmaceuticals Private Limited this company₹15.03 Lakh (FY 2021)••••••••-8.0%••••Amravati, Maharashtra, India
Epitask Pharmaceuticals Private Limited₹15.01 Lakh (FY 2018)••••••••837.0%••••Wavanje, Maharashtra, India
Nahush Pharmaceuticals Private Limited₹15.01 Lakh (FY 2025)••••••••••••Patna, Bihar, India
Fatonex Pharmaceuticals Private Limited₹14.99 Lakh (FY 2025)••••••••-16.0%••••Virar East Palghar, Maharashtra, India
Medimount Pharmaceuticals Private Limited₹14.98 Lakh (FY 2023)••••••••-60.0%••••Badlapur, Maharashtra, India
Biomash Pharmaceuticals Private Limited₹14.98 Lakh (FY 2024)••••••••-25.0%••••Jaipur, Rajasthan, India

Peers are the five companies nearest above and the five nearest below Stattlich Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Stattlich Pharmaceuticals Private Limited

Stattlich Pharmaceuticals Private Limited is audited by AGRAWALNAREDI&CO for the financial year 2017.

NameStatusAppointment DateCessation Date
AGRAWALNAREDI&COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Stattlich Pharmaceuticals Private Limited

Stattlich Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Vinod Jivanrao ThakareDirector30 Aug 201610 Years 1 MonthsCurrent
Rajesh Ramdas MankeDirector30 Aug 201610 Years 1 MonthsCurrent

Ownership and Shareholding of Stattlich Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Stattlich Pharmaceuticals Private Limited

Stattlich Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Stattlich Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Stattlich Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Stattlich Pharmaceuticals Private Limited

Stattlich Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Rajesh Ramdas Manke was appointed as Director on 30 Aug 2016.

AGM
Stattlich Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Filing
Stattlich Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Nagpur.
Appointed
Rajesh Ramdas Manke was appointed as Director.
Appointed
Vinod Jivanrao Thakare was appointed as Director.
Incorporation
30 Aug 2016
Stattlich Pharmaceuticals Private Limited was registered on 30 Aug 2016 with Roc Nagpur & aged 10 years 1 month as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Stattlich Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Stattlich Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Stattlich Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Stattlich Pharmaceuticals Private Limited

Stattlich Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAXCS5617F1ZUMaharashtraActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Stattlich Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Stattlich Pharmaceuticals Private Limited

Stattlich Pharmaceuticals is an active private limited company based in Amravati, Maharashtra, India. The company works in other wholesale, within the trading industry. It was incorporated on 30 August 2016 (10+ years old) and is registered under CIN U51909MH2016PTC285349.

Stattlich Pharmaceuticals reported revenue of ₹15.03 Lakh for FY 2021 (down 8% YoY).

Stattlich Pharmaceuticals has 2 current directors:

Stattlich Pharmaceuticals reported a net loss of ₹2,715 (net margin -0.2%) and EBITDA of -₹2,715 (EBITDA margin -0.2%) for FY 2021, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Stattlich Pharmaceuticals is -8% over three years. In the latest year (FY 2021) revenue fell 8%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Stattlich Pharmaceuticals is 27AAXCS5617F1ZU, registered in Maharashtra.

The CIN (Corporate Identification Number) of Stattlich Pharmaceuticals is U51909MH2016PTC285349. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Stattlich Pharmaceuticals was incorporated on 30 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Nagpur.

The peers of Stattlich Pharmaceuticals by revenue are Moon Rock Pharmaceuticals Private Limited, Synthecis Pharmaceuticals Private Limited, Awesome Pharmaceuticals Private Limited, Kalysta Pharmaceuticals Private Limited, Eshwar Pharmaceuticals LLP and 5 more, all in the Pharma industry (Pharmaceuticals).

Rajesh Ramdas Manke was appointed as Director on 30 Aug 2016. Vinod Jivanrao Thakare was appointed as Director on 30 Aug 2016.

The registered office of Stattlich Pharmaceuticals is at Madhuban Colony Shanti Nagar Yavatmal Road BH Gurudeo Provision New Town Badnera, Amravati, Maharashtra, India – 444701.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available